Alzheimer’s disease
-
Malvern Biotechnology Company Develops New Blood Test to Diagnose Alzheimer’s
Malvern biotechnology company Fujirebio Diagnostics has developed a revolutionary new test to diagnose Alzheimer’s disease, writes Harold Brubaker for The Philadelphia Inquirer. Previously, FDA-approved Alzheimer’s…
-
Weekend Wanderer: With Friends Like These …
As you might imagine, Willie’s friends — a cohort of fellow independent-living cronies — were aghast at Willie’s move to memory care. Even if it…
-
Chester Springs Woman One of Nation’s First Patients for Alzheimer’s Treatment
Karen Chung of Chester Springs has received one of the nation’s first treatments for early symptomatic Alzheimer’s disease, write Yukare Nakayama and Cherise Lynch for NBC10…
-
Understanding Alzheimer’s: Key Signs and Proactive Steps for Caregivers
Every September — World Alzheimer’s Month — the public is reminded of startling statistics about this devastating form of dementia that affects memory, thinking, and…
-
Malvern-Based Annovis Bio to Focus Future Development of Its Experimental Drug on Early Alzheimer’s Patients
Malvern-based Annovis Bio plans to focus on patients who have the early form of Alzheimer’s disease in the future development of its experimental treatment for…
-
Freedom Village: What Is a Person-Centered Approach to Dementia Care?
When you’re searching for senior care for a loved one with memory loss, look for person-centered dementia care, a place where that person will be…
-
Inspired by Grandfather’s Journey, Malvern Teen Champions Alzheimer’s Awareness
Malvern teenager Vincent Yao is getting recognized for his contributions to Alzheimer’s awareness, writes Richard Ilgenfritz for Main Line Media News. His grandfather lived…
-
SageLife Delivers Results for Individuals with Parkinson’s and Movement Disorders
According to the Parkinson’s Foundation, nearly one million people in the U.S. are living with Parkinson’s disease (PD), and that number is expected to rise…
-
Private Stock Sale Nets Half a Mil for Local Biopharma Company Battling Alzheimer’s, Parkinson’s
Berwyn-based QR Pharma, the biopharmaceutical company developing treatments for a number of neurological disorders, including Alzheimer’s and Parkinson’s diseases, has raised $530,000 in a private…























































